93 related articles for article (PubMed ID: 9792304)
41. Synergistic suppression of the clonogenicity of U937 leukemic cells by combinations of recombinant human interleukin 4 and granulocyte colony-stimulating factor.
Maekawa T; Sonoda Y; Kuzuyama Y; Inazawa J; Kimura S; Nakamichi K; Abe T
Exp Hematol; 1992 Nov; 20(10):1201-7. PubMed ID: 1385197
[TBL] [Abstract][Full Text] [Related]
42. Granulocyte-macrophage colony-stimulating factor and interleukin 4 induce the malignant transformation of the bone marrow-derived human adult mesenchymal stem cells.
Zhou XG; Yang Y; Yang JS; Zhou J; Fang TL; Dai WD; Chen ZR
Chin Med J (Engl); 2011 Mar; 124(5):729-33. PubMed ID: 21518567
[TBL] [Abstract][Full Text] [Related]
43. Improved detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide and interleukin-2 stimulation: A Belgian multicentric study.
Put N; Konings P; Rack K; Jamar M; Van Roy N; Libouton JM; Vannuffel P; Sartenaer D; Ameye G; Speleman F; Herens C; Poirel HA; Moreau Y; Hagemeijer A; Vandenberghe P; Michaux L;
Genes Chromosomes Cancer; 2009 Oct; 48(10):843-53. PubMed ID: 19582829
[TBL] [Abstract][Full Text] [Related]
44. Long-term bone marrow cultured stromal cells regulate myeloma tumour growth in vitro: studies with primary tumour cells and LTBMC-dependent cell lines.
Bloem AC; Lamme T; de Smet M; Kok H; Vooijs W; Wijdenes J; Boom SE; Lokhorst HM
Br J Haematol; 1998 Jan; 100(1):166-75. PubMed ID: 9450806
[TBL] [Abstract][Full Text] [Related]
45. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
[TBL] [Abstract][Full Text] [Related]
46. Differential sensitivity of human myeloma cell lines and normal bone marrow colony forming cells to a recombinant diphtheria toxin-interleukin 6 fusion protein.
Chadwick DE; Jean LF; Jamal N; Messner HA; Murphy JR; Minden MD
Br J Haematol; 1993 Sep; 85(1):25-36. PubMed ID: 8251407
[TBL] [Abstract][Full Text] [Related]
47. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow.
Reid CD; Stackpoole A; Meager A; Tikerpae J
J Immunol; 1992 Oct; 149(8):2681-8. PubMed ID: 1383322
[TBL] [Abstract][Full Text] [Related]
48. The relationship between different high proliferative potential colony-forming cells in mouse bone marrow.
Kriegler AB; Verschoor SM; Bernardo D; Bertoncello I
Exp Hematol; 1994 May; 22(5):432-40. PubMed ID: 7513652
[TBL] [Abstract][Full Text] [Related]
49. In vitro differentiation and proliferation of human hematopoietic progenitors: the effects of interleukins 1 and 6 are indirectly mediated by production of granulocyte-macrophage colony-stimulating factor and interleukin 3.
Migliaccio G; Migliaccio AR; Adamson JW
Exp Hematol; 1991 Jan; 19(1):3-10. PubMed ID: 1989893
[TBL] [Abstract][Full Text] [Related]
50. Hematopoietic growth factors and glucocorticoids synergize to mimic the effects of IL-1 on granulocyte differentiation and IL-1 receptor induction on bone marrow cells in vivo.
Dubois CM; Neta R; Keller JR; Jacobsen SE; Oppenheim JJ; Ruscetti F
Exp Hematol; 1993 Feb; 21(2):303-10. PubMed ID: 7678814
[TBL] [Abstract][Full Text] [Related]
51. Recombinant GM-CSF/IL-3 fusion protein: its effect on in vitro human megakaryocytopoiesis.
Bruno E; Briddell RA; Cooper RJ; Brandt JE; Hoffman R
Exp Hematol; 1992 May; 20(4):494-9. PubMed ID: 1373690
[TBL] [Abstract][Full Text] [Related]
52. The role of recombinant human M-CSF, IL-3, GM-CSF and calcitriol in clonal development of osteoclast precursors in primate bone marrow.
Povolny BT; Lee MY
Exp Hematol; 1993 Apr; 21(4):532-7. PubMed ID: 7681783
[TBL] [Abstract][Full Text] [Related]
53. Molecular and biologic characterization of a newly established Philadelphia-positive acute lymphoblastic leukemia cell line (Z-33) with an autocrine response to GM-CSF.
Estrov Z; Talpaz M; Ku S; Harris D; LaPushin R; Koller CA; Hirsh-Ginsberg C; Huh Y; Yee G; Kurzrock R
Leukemia; 1996 Sep; 10(9):1534-43. PubMed ID: 8751477
[TBL] [Abstract][Full Text] [Related]
54. Functional granulocyte/macrophage colony stimulating factor receptor is constitutively expressed on neoplastic plasma cells and mediates tumour cell longevity.
Villunger A; Egle A; Kos M; Egle D; Tinhofer I; Henn T; Uberall F; Maly K; Greil R
Br J Haematol; 1998 Sep; 102(4):1069-80. PubMed ID: 9734660
[TBL] [Abstract][Full Text] [Related]
55. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
56. Requirement of soluble factors produced by bone marrow stromal cells on the growth of novel established human myeloma cell line.
Aikawa S; Hatta Y; Tanaka M; Kaneita Y; Yasukawa K; Sawada U; Horie T; Tsuboi I; Aizawa S
Int J Oncol; 2003 Mar; 22(3):631-7. PubMed ID: 12579318
[TBL] [Abstract][Full Text] [Related]
57. Interaction of granulocyte-macrophage colony-stimulating factor and interleukin 3 in human long-term bone marrow culture.
Gibson FM; Bagnara M; Ioannidou E; Gordon-Smith EC
Exp Hematol; 1992 Feb; 20(2):235-40. PubMed ID: 1544393
[TBL] [Abstract][Full Text] [Related]
58. Conventional cytogenetics in myeloma.
Campbell LJ
Methods Mol Med; 2005; 113():37-47. PubMed ID: 15968093
[TBL] [Abstract][Full Text] [Related]
59. Generation of dendritic cells from adherent cells of cord blood by culture with granulocyte-macrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha.
Zheng Z; Takahashi M; Narita M; Toba K; Liu A; Furukawa T; Koike T; Aizawa Y
J Hematother Stem Cell Res; 2000 Aug; 9(4):453-64. PubMed ID: 10982243
[TBL] [Abstract][Full Text] [Related]
60. Optimal in vitro culture conditions for murine predominant immature CD8a+ dendritic cells.
Na N; Xu L; Cao KY; Luo Y; Yuan GQ; Xiang P; Hong LQ; Li SN
Chin Med J (Engl); 2009 Feb; 122(3):344-8. PubMed ID: 19236816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
